Date on which the share buy-back programme was announced: 5 June 2023.

The duration of the buy-back programme: 5 June 2023 until no later than 31 December 2023 or the maximum share size or consideration has been reached.

Size of the buy-back programme: Up to 400,000 shares, for a maximum consideration of NOK 4,000,000.

From 5 June 2023 until 13 June 2023, Nordhealth has purchased a total of 20,878 own shares at an average price of NOK 23.2015 per share.

Aggregated overview of transactions per day:

Date Aggregate daily Weighted Total
volume (# of average price transaction
shares) (NOK) value (NOK)
05.06.2023 00:00:00 1,721 24.4023 41,996.36
06.06.2023 00:00:00 760 23.9720 18,218.72
07.06.2023 00:00:00 605 23.8354 14,420.42
08.06.2023 00:00:00 0 n.a. n.a.
09.06.2023 00:00:00 0 n.a. n.a.
12.06.2023 00:00:00 17,791 23.0309 409,742.74
13.06.2023 00:00:00 1 23.6000 23.60

Previously disclosed buy-backs 0 n.a. 0.00
under the programme (aggregate)
Total purchased under the 20,878 23.2015 484,401.84
programme

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For further information, please contact:

Mari Orttenvuori, CFO

mari.orttenvuori@nordhealth.com

+358 46 8765 233